PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PRC Clinical

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PRC Clinical Announces Expansion of San Francisco Bay Area Offices - PRC Clinical today announced the expansion of its Bay Area offices to a larger facility in San Bruno, California. The company provides Phase I-IV contract services include project management, regional site monitoring, and site payment administration
PRC Clinical Announces Expansion of San Francisco Bay Area Offices

 

NewswireToday - /newswire/ - San Francisco, CA, United States, 2011/10/13 - PRC Clinical today announced the expansion of its Bay Area offices to a larger facility in San Bruno, California. The company provides Phase I-IV contract services include project management, regional site monitoring, and site payment administration.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“Our expanded building space will allow us to better serve our study Sponsors by making more efficient use of in-house staff as well as improvements to Essential Document housing and internal communication processes” said PRC Clinical Chief Executive Officer, Curtis Head. “We are pursuing our growth strategies of working with new Sponsors, increasing our presence with existing Sponsors and expanding into wider US geographies and anticipate a significant increase in our clinical management department” said Saira Singh, Senior Director, Business Development.
About PRC Clinical

PRC Clinical (Professional Research Consulting, Inc.), founded in 2002 and headquartered in San Francisco, is a privately held, niche Contract Research Organization (CRO) specializing in phase I-IV, clinical trial management services for virtual, small and mid-size pharmaceutical, biotechnology and medical device companies. PRC Clinical project teams are comprised of highly skilled and experienced clinical professionals, who are dedicated to a swift study start-up, meeting enrollment goals and on-time completion of the study within the budget. PRC Clinical has a broad range of therapeutic experience which includes cardiovascular, musculoskeletal, pulmonary, oncology, and neurology. PRC Clinical has significant experience in conducting registries and orphan drug trials.

PRC Clinical core services include trial management, regional monitoring, and Investigator payment services. Other consulting services include protocol development, clinical study report writing, medical monitoring, and clinical and regulatory auditing. Through established preferred partnerships, PRC Clinical also provides other clinical trial services, including data management, pharmacovigilance, and central and local laboratory services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PRC Clinical

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PRC Clinical Announces Expansion of San Francisco Bay Area Offices

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Saira Singh - PRCclinical.com 
877-519-6001 ssingh[.]prcclinical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PRC Clinical securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PRC Clinical / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)